Jingyu Xiang

Medicine & Life Sciences

1. Neoplasms 100%
2. Adult T Cell Leukemia Lymphoma 98%
3. Bone and Bones 93%
4. Integrins 67%
5. Breast Neoplasms 63%
6. Multiple Myeloma 59%
7. POL5551 58%
8. TCH-013 50%
9. Oncogenes 48%
10. Granulocyte-Macrophage Colony-Stimulating Factor 48%
11. Hematopoietic Stem Cell Mobilization 48%
12. Growth 47%
13. Macrophages 46%
14. Nanoparticles 44%
15. Neoplasm Metastasis 44%
16. fumagillin 44%
17. Deltaretrovirus 41%
18. Cytokine Release Syndrome 41%
19. Bone Neoplasms 40%
20. Parathyroid Hormone-Related Protein 39%
21. Imidazolines 38%
22. heparanase 38%
23. Human T-lymphotropic virus 1 38%
24. Triple Negative Breast Neoplasms 37%
25. T-Cell Leukemia 34%
26. Bone Diseases 34%
27. Osteoclasts 34%
28. Tumor Microenvironment 34%
29. Hedgehogs 33%
30. Zoledronic Acid 33%
31. Arginase 33%
32. Coronavirus 32%
33. Purinergic P1 Receptors 31%
34. Bortezomib 31%
35. Granulocyte Colony-Stimulating Factor 31%
36. Prodrugs 30%
37. Hematopoietic Stem Cells 30%
38. Stromal Cells 29%
39. T-Lymphocytes 29%
40. Myeloid Cells 29%
41. Lipase 28%
42. eribulin 28%
43. Tissue Donors 26%
44. Proteasome Endopeptidase Complex 26%
45. Bone Remodeling 26%
46. Therapeutics 26%
47. Cadherins 25%
48. Adenosine Diphosphate 25%
49. Acetates 25%
50. Drug Therapy 23%